Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Abdulrahman, Theyab"'
Autor:
Nouf S. Al-Numair, Abdulrahman Theyab, Faisal Alzahrani, Anwar M. Shams, Ibrahim O. Al-Anazi, Atif Abdulwahab A. Oyouni, Osama M. Al-Amer, Charalampos Mavromatis, Islam M. Saadeldin, Wed A. Abdali, Yousef M. Hawsawi
Publikováno v:
Cancer Cell International, Vol 22, Iss 1, Pp 1-18 (2022)
Abstract Cancer is a major health concern and accounts for one of the main causes of death worldwide. Innovative strategies are needed to aid in the diagnosis and treatment of different types of cancers. Recently, there has been an evolving interest
Externí odkaz:
https://doaj.org/article/02f6b195d0ef4688b8c845a28b4770b8
Autor:
Khalaf F. Alsharif, Asmaa A. Hamad, Mohamed A. Alblihd, Fatma Abo Zakaib Ali, Sherine Ahmed Mohammed, Abdulrahman Theyab, Osama M. Al-Amer, Malik Saad Almuqati, Abdulraheem Ali Almalki, Alaa Jameel A. Albarakati, Khalid J. Alzahrani, Ashraf Albrakati, Mohammad Hamed Albarakati, Doaa Abass, Maha S. Lokman, Ehab Kotb Elmahallawy
Publikováno v:
Frontiers in Veterinary Science, Vol 10 (2023)
BackgroundDiabetes mellitus (DM) is a chronic metabolic disorder. Hepatopathy is one of the serious effects of DM Melatonin (MT) is a potent endogenous antioxidant that can control insulin output. However, little information is available about the po
Externí odkaz:
https://doaj.org/article/5763fa9ea16c4360aaf46440308bd23a
Publikováno v:
Clinical Case Reports, Vol 11, Iss 6, Pp n/a-n/a (2023)
Key Clinical Message Rhizomelic chondrodysplasia punctata (RCDP) is a rare disorder (~1 in 100,000 live births) of faulty plasmalogen biosynthesis and defective peroxisomal metabolism. RCDP type 2 is specifically caused by glyceronephosphate O‐acyl
Externí odkaz:
https://doaj.org/article/7a4274dc35104ec3acd78d8988861fb3
Autor:
Arshad Husain Rahmani, Ahmad Almatroudi, Khaled S. Allemailem, Hajed Obaid A. Alharbi, Wanian M. Alwanian, Basmah Awwadh Alhunayhani, Mohammad Algahtani, Abdulrahman Theyab, Nahlah Makki Almansour, Ahmed N. Algefary, Solaiman Saleh Ali Aldeghaim, Amjad Ali Khan
Publikováno v:
Biomedicines, Vol 11, Iss 12, p 3205 (2023)
Cancer is a major public health concern worldwide in terms of mortality. The exact reason behind the development of cancer is not understood clearly, but it is evidenced that alcohol consumption, radiation, and exposure to chemicals are main players
Externí odkaz:
https://doaj.org/article/17c591fce2314cd7917180b7e1525d18
Autor:
Yousef M. Hawsawi, Anwar Shams, Abdulrahman Theyab, Wed A. Abdali, Nahed A. Hussien, Hanan E. Alatwi, Othman R. Alzahrani, Atif Abdulwahab A. Oyouni, Ahmad O. Babalghith, Mousa Alreshidi
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-23 (2022)
Abstract The full-length BRCA1-associated RING domain 1 (BARD1) gene encodes a 777-aa protein. BARD1 displays a dual role in cancer development and progression as it acts as a tumor suppressor and an oncogene. Structurally, BARD1 has homologous domai
Externí odkaz:
https://doaj.org/article/a6082ff45d8b4d468e7c52be8ebeb5dc
Autor:
Jency Roshni, R. Vaishali, KS Ganesh, N. Dharani, Khalid J. Alzahrani, Hamsa Jameel Banjer, Ali H. Alghamdi, Abdulrahman Theyab, Shiek SSJ Ahmed, Shankargouda Patil
Publikováno v:
Journal of Infection and Public Health, Vol 15, Iss 6, Pp 662-669 (2022)
Background: SARS-CoV-2, an emerged strain of corona virus family became almost serious health concern worldwide. Despite vaccines availability, reports suggest the occurrence of SARS-CoV-2 infection even in a vaccinated population. With frequent evol
Externí odkaz:
https://doaj.org/article/4b81bace5ab5448d8b1c036e8f9b5117
Autor:
Nahed N. Mahrous, Yahya F. Jamous, Ahmad M. Almatrafi, Deema I. Fallatah, Abdulrahman Theyab, Bayan H. Alanati, Suliman A. Alsagaby, Munifa K. Alenazi, Mohammed I. Khan, Yousef M. Hawsawi
Publikováno v:
Biomedicines, Vol 11, Iss 10, p 2762 (2023)
Alport syndrome (AS) is a rare genetic disorder categorized by the progressive loss of kidney function, sensorineural hearing loss and eye abnormalities. It occurs due to mutations in three genes that encode for the alpha chains of type IV collagen.
Externí odkaz:
https://doaj.org/article/67569b7fa2af4048b4c9c6fe610191e6
Autor:
Abdulrahman Theyab, Khalaf F. Alsharif, Khalid J. Alzahrani, Atif Abdulwahab A. Oyouni, Yousef MohammedRabaa Hawsawi, Mohammad Algahtani, Saad Alghamdi, Amal F. Alshammary
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
Over the last 20 years, granulocyte colony-stimulating factors (G-CSFs) have become the major therapeutic option for the treatment of patients with neutropenia. Most of the current G-CSFs require daily injections, which are inconvenient and expensive
Externí odkaz:
https://doaj.org/article/c751b6c4a840494bbb06ebe7be3f9a5d
Autor:
Nobendu Mukerjee, Khattab Al-Khafaji, Swastika Maitra, Jaafar Suhail Wadi, Punya Sachdeva, Arabinda Ghosh, Rahul Subhash Buchade, Somdatta Yashwant Chaudhari, Shailaja B. Jadhav, Padmashree Das, Mohammad Mehedi Hasan, Md. Habibur Rahman, Ghadeer M. Albadrani, Ahmed E. Altyar, Mohamed Kamel, Mohammad Algahtani, Khlood Shinan, Abdulrahman Theyab, Mohamed M. Abdel-Daim, Ghulam Md. Ashraf, Md. Mominur Rahman, Rohit Sharma
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 15 (2022)
Alzheimer’s disease (AD) is the most common neurodegenerative disorder in the world, affecting an estimated 50 million individuals. The nerve cells become impaired and die due to the formation of amyloid-beta (Aβ) plaques and neurofibrillary tangl
Externí odkaz:
https://doaj.org/article/eaaf11785aa94bb48d08b66cc9bd7e3b
Autor:
Mohamed Sayed Zaazouee, Asmaa Gomaa Alwarraqi, Yasmine Adel Mohammed, Mohamed A. Badheeb, Abdullah Mohamed Farhat, Mohammed Eleyan, Afnan Morad, Marwa Abdel-Aziz Zeid, Aya Shaban Mohamed, Hazem AbuEl-Enien, Ahmed Abdelalim, Ahmed Bostamy Elsnhory, Yasmin S. M. Hrizat, Nagat Taha Altahir, Doaa Atef, Alaa Ahmed Elshanbary, Khalaf F. Alsharif, Khalid J. Alzahrani, Mohammad Algahtani, Abdulrahman Theyab, Yousef M. Hawsawi, Ahmed A. Aldarmahi, Mohamed M. Abdel-Daim
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Dupilumab is a human monoclonal antibody directed against the alpha subunit of the interleukin-4 receptor and inhibits the signaling of IL-4 and IL-13. It is approved for treating asthma and other type-2 inflammatory diseases. There is a
Externí odkaz:
https://doaj.org/article/3544b8575c1c4d958220176a876ad7f3